Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument

Key facts

Sponsor

Actelion

Principal Investigator

Alain Romero, PharmD, PhD

Actelion Pharmaceuticals US, Inc

Intervention

Macitentan(drug)

Enrollment

284 enrolled

Eligibility

18 years · All sexes

Timeline

2013 – 2015

Study locations (30)

• Cardiovascular Associates of the Southeast, LLC, Birmingham, Alabama, United States
• University of Alabama at Birmingham, Birmingham, Alabama, United States
• Pulmonary Associates, PA, Phoenix, Arizona, United States
• Mayo Clinic Arizona, Phoenix, Arizona, United States
• Cedars-Sinai Medical Center, Beverly Hills, California, United States
• UCSF Fresno, Fresno, California, United States
• UCSD Medical Center, Pulmonary Department, La Jolla, California, United States
• VAGLAHS, VA Greater LA Healthcare System, Los Angeles, California, United States
• University of California Los Angeles, Los Angeles, California, United States
• University of California San Francisco Medical Center, San Francisco, California, United States
• Stanford University, Stanford, California, United States
• Los Angeles Biomedical Research Institute, Torrance, California, United States
• University of Colorado, Aurora, Colorado, United States
• MedStar Georgetown University Hospital, Washington D.C., District of Columbia, United States
• Medstar Washington Hospital Center, Washington D.C., District of Columbia, United States
• +15 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Drug- or toxin-induced pulmonary arterial hypertension

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT07529821
  Additional Effects of Pilates Breathing and Diaphragmatic Breathing Combined With Moderate Intensity Continuous Treadmill Training on Blood Pressure, Chest Expansion, Pulmonary Function and Quality Of Life in Pre-hypertensive Patients
  Foundation University Islamabad
• ACTIVE NOT RECRUITINGNCT07312227
  A Prospective Longitudinal Observational Cohort Study of Pregnant Women Residing at High Altitude in Bolivia
  Massachusetts General Hospital
• ENROLLING BY INVITATIONNANCT07558460
  Virtual Reality in Patients With Pulmonary Hypertension: A Randomized Controlled Trial
  Istanbul University - Cerrahpasa
• RECRUITINGPHASE2NCT07318597
  Phase 2 Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)
  Regeneron Pharmaceuticals
• RECRUITINGPHASE1NCT06872112
  A Study Evaluating the Safety and Tolerability of Artesunate in Patients With Pulmonary Arterial Hypertension
  Joseph C. Wu
• RECRUITINGPHASE2NCT06351345
  129 Xenon Imaging in Patients Treated With Sotatercept
  Bastiaan Driehuys
• RECRUITINGPHASE4NCT07140484
  Sotatercept in Pulmonary Arterial Hypertension
  University of Alberta
• RECRUITINGPHASE2NCT07175038
  A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
  AllRock Bio, Inc.

See all trials for Drug- or toxin-induced pulmonary arterial hypertension →